Two Omaha women lost more than 300 lbs. combined with injections of a GLP-1 drug, which are used increasingly for weight loss ...

Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...

A recent study from the University of Pennsylvania has confirmed that the injectable medication semaglutide can lead to major ...

Plus, check out our handy semaglutide weight loss dosage chart for an easy-to-follow ... It’s intended for people who have obesity (a body mass index, or BMI, of 30 or higher) and those with ...

In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

Hallie Levine is an award-winning health and medical journalist who frequently contributes to AARP, Consumer Reports, the New York Times, and Health.com. She lives in Fairfield, CT, with her three ...

Most people regain some of the weight they lost after stopping semaglutide. However, physical activity and a balanced diet may help you keep some weight off. Share on Pinterest LeoPatrizi/Getty ...

After the best two-year stretch for the S&P 500 (^GSPC) since the late 1990s, few on Wall Street are calling for an end to the bull market run, and this optimism serves as the key throughline in ...

Originally approved by the FDA in 2017 to treat type 2 diabetes, semaglutide-based medications like Ozempic and Wegovy have now become the hottest off-label weight-loss solution. With a staggering 15 ...

Enobosarm demonstrated a statistically significant benefit in preserving lean mass in patients with overweight or obesity undergoing treatment with semaglutide ... square means analysis using gender ...